Elliott Sigal

Elliott Sigal

INDEPENDENT DIRECTORatAlnylam Pharmaceuticals· In proxies 2023–2025

Elliott Sigal sits on 9 public boards.

Experience

  1. Alnylam PharmaceuticalsPublic company · 3 yr
    • INDEPENDENT DIRECTOR2023 – Present · 3 yrStock in role 0%
  2. Vir BiotechnologyPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Tessera TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. Affinia Therapeutics Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  5. Rani Therapeutics Holdings, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Seres Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Spexis AG.Public company
    • Director? – PresentNo stock prices for these years
  8. Vir Biotechnology, Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. Surface Oncology Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Adaptimmune TherapeuticsPublic company · 9 yr
    • Director2014 – 2023 · 9 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?